RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000126.xml
Intensivmedizin up2date 2022; 18(01): 9-14
DOI: 10.1055/a-1553-2078
DOI: 10.1055/a-1553-2078
SOP/Arbeitsablauf
SOP Vakzininduzierte immunogene thrombotische Thrombozytopenie
![](https://www.thieme-connect.de/media/intensiv-u2d/202201/lookinside/thumbnails/10-1055-a-1553-2078_im15532078_sop-1.jpg)
In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für perioperativ und intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.
Publikationsverlauf
Artikel online veröffentlicht:
11. März 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Greinacher A, Thiele T, Warkentin TE. et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med 2021; 384: 2092-2101 DOI: 10.1056/NEJMoa2104840. (PMID: 33835769)
- 2 Pavord S, Scully M, Hunt BJ. et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med 2021; 385: 1680-1689 DOI: 10.1056/NEJMoa2109908. (PMID: 34379914)
- 3 Perry RJ, Tamborska A, Singh B. et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 2021; 398: 1147-1156 DOI: 10.1016/S0140-6736(21)01608-1. (PMID: 34370972)
- 4 Schultz NH, Sorvoll IH, Michelsen AE. et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384: 2124-2130 DOI: 10.1056/NEJMoa2104882. (PMID: 33835768)
- 5 Scully M, Singh D, Lown R. et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384: 2202-2211 DOI: 10.1056/NEJMoa2105385. (PMID: 33861525)
- 6 Tiede A, Sachs UJ, Czwalinna A. et al. Prothrombotic immune thrombocytopenia after COVID-19 vaccine. Blood 2021; 138: 350-353 DOI: 10.1182/blood.2021011958. (PMID: 34323939)
- 7 Muir KL, Kallam A, Koepsell SA. et al. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. N Engl J Med 2021; 384: 1964-1965 DOI: 10.1056/NEJMc2105869. (PMID: 33852795)
- 8 Huynh A, Kelton JG, Arnold DM. et al. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature 2021; 596: 565-569 DOI: 10.1038/s41586-021-03744-4. (PMID: 34233346)
- 9 Greinacher A. Heparin-Induced Thrombocytopenia. N Engl J Med 2015; 373: 1883-1884 DOI: 10.1111/jth.15344. (PMID: 33872452)
- 10 Salih F, Schonborn L, Kohler S. et al. Vaccine-Induced Thrombocytopenia with Severe Headache. N Engl J Med 2021; 385: 2103-2105 DOI: 10.1056/NEJMc2112974. (PMID: 34525282)
- 11 Greinacher A, Langer F, Makris M. et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources. J Thromb Haemost 2022; 20: 149-156 DOI: 10.1111/jth.15572. (PMID: 34693641)
- 12 Vayne C, Rollin J, Gruel Y, Pouplard C. et al. PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 376-378 DOI: 10.1056/NEJMc2106383. (PMID: 34010527)
- 13 Platton S, Bartlett A, MacCallum P. et al. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 2021; 19: 2007-2013 DOI: 10.1111/jth.15362. (PMID: 33973336)
- 14 Sachs UJ, Cooper N, Czwalinna A. et al. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison. Thromb Haemost 2021; 121: 1622-1627 DOI: 10.1055/a-1535-9002. (PMID: 34169493)
- 15 Thiele T, Weisser K, Schonborn L. et al. Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Lancet Reg Health Eur 2022; 12: 100270 DOI: 10.1016/j.lanepe.2021.100270. (PMID: 34901912)
- 16 Graf T, Thiele T, Klingebiel R. et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol 2021; 268: 4483-4485 DOI: 10.1007/s00415-021-10599-2. (PMID: 34023956)
- 17 Oldenburg J, Klamroth R, Langer F. et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. Hamostaseologie 2021; 41: 184-189 DOI: 10.1055/a-1469-7481. (PMID: 33822348)
- 18 Bourguignon A, Arnold DM, Warkentin TE. et al. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 720-728 DOI: 10.1056/NEJMoa2107051. (PMID: 34107198)
- 19 Gunther A, Bramer D, Pletz MW. et al. Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report. Vaccines (Basel) 2021; 9: 1344 DOI: 10.3390/vaccines9111344. (PMID: 34835275)
- 20 Gessler F, Schmitz AK, Dubinski D. et al. Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT. J Clin Med 2021; 10: 2777 DOI: 10.3390/jcm10132777. (PMID: 34202817)
- 21 Bundesärztekammer. Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten – Gesamtnovelle 2020. Zugriff am 05. Januar 2022 unter: https://www.bundesaerztekammer.de/aerzte/medizin-ethik/wissenschaftlicher-beirat/veroeffentlichungen/haemotherapietransfusionsmedizin/querschnitt-leitlinie/
- 22 Patriquin CJ, Laroche V, Selby R. et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 857-859 DOI: 10.1056/NEJMc2109465. (PMID: 34233107)
- 23 Schonborn L, Thiele T, Kaderali L. et al. Decline in Pathogenic Antibodies over Time in VITT. N Engl J Med 2021; 385: 1815-1816 DOI: 10.1056/NEJMc2112760. (PMID: 34496199)